Short-term Impact of COVID-19 Lockdown on Metabolic Control of Type 2 Diabetes

Determining the Impact of COVID-19 Lockdown on Metabolic Control in Individuals With Type 2 Diabetes

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04501991

Enrollment

114

Registered

2020-08-06

Start date

2020-03-11

Completion date

2020-06-30

Last updated

2020-08-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic Control, Type 2 Diabetes

Keywords

T2D, Sars-Cov-2, COVID-19 lockdown, metabolic control, sedentary

Brief summary

The strict rules applied in Italy during the recent COVID-19 pandemic, with the prohibition to attend any regular outdoor activity, are likely to influence the degree of metabolic control of patients with type 2 diabetes. The aim of this observational, prospective, single centre study was to evaluate the immediate impact of the lockdown rules on the metabolic profile of a cohort of patients with type 2 diabetes.

Detailed description

All the patients with type 2 diabetes who were previously scheduled for a follow-up visit in our outpatient diabetes clinic during the lockdown for COVID-19 (March 9, 2020-May 04, 2020) were contacted by phone. Patients who accepted to take part of the study received a medical prescription for routine analysis via email. They were asked to perform blood drawing one week after the end of the lockdown period and transmitted us the results. We then compared the metabolic profile tested one week after the end of the lockdown with the last value and the mean of the last three determinations performed before the pandemic emergency.

Interventions

OTHERantidiabetic treatment

Every kind of antidiabetic treatment, oral or injective, were considered including patients treated only with diet

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 85 Years

Healthy volunteers

Inclusion criteria

* type 2 diabetes * at least two previous clinical records in the last two years

Exclusion criteria

* age \>85 years * first access to the outpatient clinic * type 1 diabetes

Design outcomes

Primary

Measure	Time frame	Description
Glucose	One week after the end of the lockdown period	Blood glucose was expressed in mg/dl and was determined by standard techniques.
HbA1c	One week after the end of the lockdown period	HbA1c was expressed as percentage or mmol/l and was determined by standard techniques.
Lipid profile	One week after the end of the lockdown period	Complete lipid profile (total cholesterol, HDL cholesterol, LDL cholesterol, Triglcerydes) were expressed in mg/dl or mmol/l and were determined by standard techniques.

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026